From: A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis
 | Cases (%) | Controls (%) | Odds ratio (95% confidence interval)a | Odds ratio (95% confidence interval)b |
---|---|---|---|---|
AR long-range haplotypesc | Â | Â | Â | Â |
   0-0-0-0-0-0 | 71.2 | 69.7 | 1.00 reference | 1.00 reference |
   0-1-1-0-0-1 | 8.1 | 8.1 | 0.98 (0.72 to 1.33) | 0.99 (0.72 to 1.36) |
   0-0-0-1-0-0 | 6.7 | 8.0 | 0.86 (0.62 to 1.19) | 0.82 (0.58 to 1.14) |
   1-1-1-0-1-1 | 6.4 | 5.3 | 1.19 (0.82 to 1.71) | 1.29 (0.88 to 1.88) |
   0-0-0-0-0-1 | 4.7 | 6.1 | 0.73 (0.50 to 1.07) | 0.76 (0.51 to 1.12) |
ESR2 haplotypesd | Â | Â | Â | Â |
   0-1-0-0-0 | 42.4 | 46.8 | 1.00 | 1.00 |
   1-0-0-1-0 | 27.2 | 24.7 | 1.16 (0.95 to 1.42) | 1.15 (0.94 to 1.41) |
   0-0-0-0-0 | 10.9 | 8.3 | 1.47 (1.07 to 2.01) | 1.44 (1.05 to 1.98) |
   0-0-0-1-0 | 9.1 | 9.6 | 0.99 (0.71 to 1.38) | 0.91 (0.65 to 1.28) |
PGR haplotypese | Â | Â | Â | Â |
   0-0-0-0 | 41.2 | 37.5 | 1.00 | 1.00 |
   0-0-1-0 | 34.4 | 34.2 | 0.93 (0.75 to 1.14) | 0.92 (0.75 to 1.14) |
   0-0-0-1 | 13.1 | 16.3 | 0.72 (0.55 to 0.94) | 0.73 (0.56 to 0.95) |
   1-0-0-0 | 6.3 | 7.4 | 0.75 (0.53 to 1.06) | 0.75 (0.53 to 1.07) |
CYP19, block 1 haplotypesf | Â | Â | Â | Â |
   0-0-1-0-0-0 | 39.2 | 31.2 | 1.00 | 1.00 |
   0-0-0-1-1-0 | 14.0 | 14.4 | 0.68 (0.50 to 0.94) | 0.71 (0.52 to 0.98) |
   0-0-0-0-1-0 | 10.4 | 14.4 | 0.81 (0.61 to 1.08) | 0.83 (0.62 to 1.11) |
   0-0-0-0-0-0 | 10.3 | 9.6 | 0.69 (0.51 to 0.93) | 0.71 (0.52 to 0.96) |
   1-1-0-0-1-1 | 5.5 | 6.5 | 0.58 (0.38 to 0.88) | 0.58 (0.38 to 0.88) |